The association of allergic asthma and carotid intima-media thickness in adolescence: data of the prospective early vascular ageing (EVA)-Tyrol cohort study

Bernhard Winder, Sophia J Kiechl, Nadja M Gruber, Benoît Bernar, Nina Gande, Anna Staudt, Katharina Stock, Christoph Hochmayr, Ralf Geiger, Andrea Griesmacher, Markus Anliker, Stefan Kiechl, Ursula Kiechl-Kohlendorfer, Michael Knoflach, Early Vascular Ageing (EVA)-Tyrol Study Group, Carmen Reiter, Christina Schreiner, Julia Klingenschmid, Julia Marxer, Martina Kothmayer, Maximilian Pircher, Manuela Bock-Bartl, Mandy Asare, Maximilian Bohl, Raimund Pechlaner, Bernhard Winder, Sophia J Kiechl, Nadja M Gruber, Benoît Bernar, Nina Gande, Anna Staudt, Katharina Stock, Christoph Hochmayr, Ralf Geiger, Andrea Griesmacher, Markus Anliker, Stefan Kiechl, Ursula Kiechl-Kohlendorfer, Michael Knoflach, Early Vascular Ageing (EVA)-Tyrol Study Group, Carmen Reiter, Christina Schreiner, Julia Klingenschmid, Julia Marxer, Martina Kothmayer, Maximilian Pircher, Manuela Bock-Bartl, Mandy Asare, Maximilian Bohl, Raimund Pechlaner

Abstract

Background: In recent years, there has been increasing evidence that asthma is associated with atherosclerosis and cardiovascular disease. However, data in children and adolescents are scarce and conflicting. We aimed to assess the impact of asthma with and without an allergic component on the carotid intima-media thickness in a large pediatric population.

Methods: The community-based early vascular ageing-Tyrol cohort study was performed between May 2015 and July 2018 in North, East (Austria) and South Tyrol (Italy) and recruited youngster aged 14 years and above. Medical examinations included anthropometric measurements, fasting blood analysis, measurement of the carotid intima-media thickness by high-resolution ultrasound, and a physician guided interview.

Results: The mean age of the 1506 participants was 17.8 years (standard deviation 0.90). 851 (56.5%) participants were female. 22 subjects had a physician diagnosis of non-allergic asthma, 268 had inhalative allergies confirmed by a positive radio-allergo-sorbent-test and/or prick test, and 58 had allergic asthma. Compared to healthy controls, participants with non-allergic asthma (411.7 vs. 411.7 µm; p = 0.932) or inhalative allergy (420.0 vs. 411.7 µm; p = 0.118) did not have significantly higher carotid intima-media thickness (cIMT). However, participants with allergic asthma had significantly higher cIMT (430.8 vs. 411.7; p = 0.004) compared to those without and this association remained significant after multivariable adjustment for established cardiovascular risk factors.

Conclusion: Allergic asthma in the youth is associated with an increased carotid intima-media thickness. Physicians should therefore be aware of allergic asthma as a potential cardiovascular risk factor in children and adolescents. Trial Registration Number The EVA-Tyrol Study has been retrospectively registered at clinicaltrials.gov under NCT03929692 since April 29, 2019.

Keywords: Allergic asthma; Atherosclerosis; Carotid intima-media thickness; Clinical studies.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
From: The association of allergic asthma and carotid intima-media thickness in adolescence–Data of the prospective early vascular ageing (EVA)-Tyrol cohort study

References

    1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–478. doi: 10.1111/j.1398-9995.2004.00526.x.
    1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–e603. doi: 10.1161/CIR.0000000000000485.
    1. Iribarren C, Tolstykh IV, Miller MK, Sobel E, Eisner MD. Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts. Am J Epidemiol. 2012;176(11):1014–1024. doi: 10.1093/aje/kws181.
    1. Tattersall MC, Guo M, Korcarz CE, Gepner AD, Kaufman JD, Liu KJ, Barr RG, Donohue KM, McClelland RL, Delaney JA, et al. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(6):1520–1525. doi: 10.1161/ATVBAHA.115.305452.
    1. Tuleta I, Skowasch D, Aurich F, Eckstein N, Schueler R, Pizarro C, Schahab N, Nickenig G, Schaefer C, Pingel S. Asthma is associated with atherosclerotic artery changes. PLoS ONE. 2017;12(10):e0186820. doi: 10.1371/journal.pone.0186820.
    1. Strand LB, Tsai MK, Wen CP, Chang SS, Brumpton BM. Is having asthma associated with an increased risk of dying from cardiovascular disease? A prospective cohort study of 446 346 Taiwanese adults. BMJ Open. 2018;8(5):e019992. doi: 10.1136/bmjopen-2017-019992.
    1. Pollevick ME, Xu KY, Mhango G, Federmann EG, Vedanthan R, Busse P, Holguin F, Federman AD, Wisnivesky JP. The relationship between asthma and cardiovascular disease: an examination of the Framingham offspring study. Chest. 2020 doi: 10.1016/j.chest.2020.11.053.
    1. Chung WS, Shen TC, Lin CL, Chu YH, Hsu WH, Kao CH. Adult asthmatics increase the risk of acute coronary syndrome: a nationwide population-based cohort study. Eur J Intern Med. 2014;25(10):941–945. doi: 10.1016/j.ejim.2014.10.023.
    1. Chung WS, Lin CL, Chen YF, Ho FM, Hsu WH, Kao CH. Increased stroke risk among adult asthmatic patients. Eur J Clin Invest. 2014;44(11):1025–1033. doi: 10.1111/eci.12336.
    1. Xu M, Xu J, Yang X. Asthma and risk of cardiovascular disease or all-cause mortality: a meta-analysis. Ann Saudi Med. 2017;37(2):99–105. doi: 10.5144/0256-4947.2017.99.
    1. Bellia V, Pedone C, Catalano F, Zito A, Davì E, Palange S, Forastiere F, Incalzi RA. Asthma in the elderly: mortality rate and associated risk factors for mortality. Chest. 2007;132(4):1175–1182. doi: 10.1378/chest.06-2824.
    1. Schanen JG, Iribarren C, Shahar E, Punjabi NM, Rich SS, Sorlie PD, Folsom AR. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax. 2005;60(8):633–638. doi: 10.1136/thx.2004.026484.
    1. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340(2):115–126. doi: 10.1056/NEJM199901143400207.
    1. Wick G, Knoflach M, Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol. 2004;22:361–403. doi: 10.1146/annurev.immunol.22.012703.104644.
    1. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation. 2001;103(8):1064–1070. doi: 10.1161/01.cir.103.8.1064.
    1. Lampalo M, Majer M, Ferara N, Milošević M, Barišić Kutija M, Jukić I. Gender differences in relationship between body mass index and asthma. Psychiatr Danub. 2019;31(Suppl 5):786–791.
    1. Souza ECC, Pizzichini MMM, Dias M, Cunha MJ, Matte DL, Karloh M, Maurici R, Pizzichini E. Body mass index, asthma, and respiratory symptoms: a population-based study. J Bras Pneumol. 2020;46(1):e20190006. doi: 10.1590/1806-3713/e20190006.
    1. Berry M, Brightling C, Pavord I, Wardlaw A. TNF-alpha in asthma. Curr Opin Pharmacol. 2007;7(3):279–282. doi: 10.1016/j.coph.2007.03.001.
    1. Brightling C, Berry M, Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol. 2008;121(1):5–12. doi: 10.1016/j.jaci.2007.10.028.
    1. Peters MC, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4(7):574–584. doi: 10.1016/S2213-2600(16)30048-0.
    1. Carriero V, Bertolini F, Sprio AE, Bullone M, Ciprandi G, Ricciardolo FLM. High levels of plasma fibrinogen could predict frequent asthma exacerbations. J Allergy Clin Immunol Pract. 2020;8(7):2392–2395.e2397. doi: 10.1016/j.jaip.2020.02.034.
    1. Akinbami LJ, Simon AE, Rossen LM. Changing trends in asthma prevalence among children. Pediatrics. 2016;137(1):1–7. doi: 10.1542/peds.2015-2354.
    1. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP, 3rd, Herderick EE, Cornhill JF. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999;281(8):727–735. doi: 10.1001/jama.281.8.727.
    1. Knoflach M, Kiechl S, Mayr A, Willeit J, Poewe W, Wick G. Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies. Arch Intern Med. 2005;165(21):2521–2526. doi: 10.1001/archinte.165.21.2521.
    1. Cakmak A, Zeyrek D, Cece H, Erel O. The relationship between carotid intima media thickness and oxidative stress in asthmatic children. Asian Pac J Allergy Immunol. 2010;28(4):256–261.
    1. Steinmann M, Abbas C, Singer F, Casaulta C, Regamey N, Haffner D, Fischer DC, Simonetti GD. Arterial stiffness is increased in asthmatic children. Eur J Pediatr. 2015;174(4):519–523. doi: 10.1007/s00431-014-2423-2.
    1. Dratva J, Caviezel S, Schaffner E, Stolz D, Rothe T, Kuenzli N, Schmidt-Trucksäss A, Zemp E, Probst-Hensch N. Is there a gender-specific association between asthma and carotid intima media thickness in Swiss adolescents? Eur J Pediatr. 2018;177(5):699–707. doi: 10.1007/s00431-018-3107-0.
    1. Akyüz Özkan E, Serin H, Khosroshahi HE, Kılıç M, Ekim M, Beysel P, Geçit UA, Domur E. Arterial stiffness, distensibility, and strain in asthmatic children. Med Sci Monit 2016, 22:251–257. 10.12659/msm.895502.
    1. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290(17):2277–2283. doi: 10.1001/jama.290.17.2277.
    1. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–467. doi: 10.1161/CIRCULATIONAHA.106.628875.
    1. Bernar B, Gande N, Stock KA, Staudt A, Pechlaner R, Geiger R, Griesmacher A, Kiechl S, Knoflach M, Kiechl-Kohlendorfer U. The Tyrolean early vascular ageing-study (EVA-Tyrol): study protocol for a non-randomized controlled trial: effect of a cardiovascular health promotion program in youth, a prospective cohort study. BMC Cardiovasc Disord. 2020;20(1):59. doi: 10.1186/s12872-020-01357-9.
    1. Torén K, Brisman J, Järvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest. 1993;104(2):600–608. doi: 10.1378/chest.104.2.600.
    1. Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr. 2010;64:2–5. doi: 10.1038/ejcn.2009.139.
    1. Knoflach M, Kiechl S, Kind M, Said M, Sief R, Gisinger M, van der Zee R, Gaston H, Jarosch E, Willeit J, et al. Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters) Circulation. 2003;108(9):1064–1069. doi: 10.1161/01.CIR.0000085996.95532.FF.
    1. Knoflach M, Kiechl S, Penz D, Zangerle A, Schmidauer C, Rossmann A, Shingh M, Spallek R, Griesmacher A, Bernhard D, et al. Cardiovascular risk factors and atherosclerosis in young women: atherosclerosis risk factors in female youngsters (ARFY study) Stroke. 2009;40(4):1063–1069. doi: 10.1161/STROKEAHA.108.525675.
    1. Kiechl S, Willeit J. The natural course of atherosclerosis. Part I: incidence and progression. Arterioscler Thromb Vasc Biol. 1999;19(6):1484–1490. doi: 10.1161/01.atv.19.6.1484.
    1. Staudt A, Stock K, Gande N, Bernar B, Hochmayr C, Pechlaner R, Kiechl SJ, Geiger R, Griesmacher A, Anliker M, et al. Impact of lifestyle and cardiovascular risk factors on early atherosclerosis in a large cohort of healthy adolescents: the early vascular ageing (EVA)-Tyrol study. Atherosclerosis. 2020;305:26–33. doi: 10.1016/j.atherosclerosis.2020.05.011.
    1. Çolak Y, Afzal S, Nordestgaard BG, Lange P. Characteristics and prognosis of never-smokers and smokers with asthma in the Copenhagen general population study. a prospective cohort study. Am J Respir Crit Care Med. 2015;192(2):172–181. doi: 10.1164/rccm.201502-0302OC.
    1. Iribarren C, Tolstykh IV, Eisner MD. Are patients with asthma at increased risk of coronary heart disease? Int J Epidemiol. 2004;33(4):743–748. doi: 10.1093/ije/dyh081.
    1. Onufrak SJ, Abramson JL, Austin HD, Holguin F, McClellan WM, Vaccarino LV. Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol. 2008;101(9):1247–1252. doi: 10.1016/j.amjcard.2007.12.024.
    1. Onufrak S, Abramson J, Vaccarino V. Adult-onset asthma is associated with increased carotid atherosclerosis among women in the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2007;195(1):129–137. doi: 10.1016/j.atherosclerosis.2006.09.004.
    1. Wang L, Gao S, Yu M, Sheng Z, Tan W. Association of asthma with coronary heart disease: a meta analysis of 11 trials. PLoS ONE. 2017;12(6):e0179335. doi: 10.1371/journal.pone.0179335.
    1. Tattersall MC, Evans MD, Korcarz CE, Mitchell C, Anderson E, DaSilva DF, Salazar LP, Gern JE, Jackson DJ, Lemanske RF, Jr, et al. Asthma is associated with carotid arterial injury in children: the Childhood Origins of Asthma (COAST) Cohort. PLoS ONE. 2018;13(9):e0204708. doi: 10.1371/journal.pone.0204708.
    1. Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS, Gupta M. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis. 2018;276:98–108. doi: 10.1016/j.atherosclerosis.2018.07.014.
    1. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112(21):3337–3347. doi: 10.1161/CIRCULATIONAHA.104.507996.
    1. Huang H, Zeng Z, Li J, Zhang L, Chen Y. Variants of arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of coronary heart disease: a meta-analysis. Arch Med Res. 2010;41(8):634–641. doi: 10.1016/j.arcmed.2010.11.001.
    1. Abueid L, Uslu Ü, Cumbul A, Velioğlu Öğünç A, Ercan F, Alican İ. Inhibition of 5-lipoxygenase by zileuton in a rat model of myocardial infarction. Anatol J Cardiol 2017, 17(4):269–275. 10.14744/AnatolJCardiol.2016.7248.
    1. Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, Shaposhnik Z, Funk CD, Lusis AJ. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res. 2002;91(2):120–126. doi: 10.1161/01.res.0000028008.99774.7f.
    1. Khan MI, Hariprasad G. Human secretary phospholipase A2 mutations and their clinical implications. J Inflamm Res. 2020;13:551–561. doi: 10.2147/JIR.S269557.
    1. Christiansen SC, Zuraw BL. Treatment of hypertension in patients with asthma. N Engl J Med. 2019;381(11):1046–1057. doi: 10.1056/NEJMra1800345.
    1. Dogra S, Ardern CI, Baker J. The relationship between age of asthma onset and cardiovascular disease in Canadians. J Asthma. 2007;44(10):849–854. doi: 10.1080/02770900701752391.
    1. Aung T, Bisognano JD, Morgan MA. Allergic respiratory disease as a potential co-morbidity for hypertension. Cardiol J. 2010;17(5):443–447.
    1. Roelofs R, Gurgel RQ, Wendte J, Polderman J, Barreto-Filho JA, Solé D, Motta-Franco J, De Munter J, Agyemang C. Relationship between asthma and high blood pressure among adolescents in Aracaju. Brazil. J Asthma. 2010;47(6):639–643. doi: 10.3109/02770901003734306.
    1. Liu CL, Zhang JY, Shi GP. Interaction between allergic asthma and atherosclerosis. Transl Res. 2016. 10.1016/j.trsl.2015.09.009.
    1. Hermans M, Lennep JRV, van Daele P, Bot I. Mast cells in cardiovascular disease: from bench to bedside. Int J Mol Sci 2019. 10.3390/ijms20143395.
    1. Marx C, Novotny J, Salbeck D, Zellner KR, Nicolai L, Pekayvaz K, Kilani B, Stockhausen S, Bürgener N, Kupka D, et al. Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps. Blood. 2019;134(21):1859–1872. doi: 10.1182/blood.2019000518.
    1. Otsuki M, Miyatake A, Fujita K, Hamasaki T, Kasayama S. Reduced carotid atherosclerosis in asthmatic patients treated with inhaled corticosteroids. Eur Respir J. 2010;36(3):503–508. doi: 10.1183/09031936.00090009.
    1. Suissa S, Assimes T, Brassard P, Ernst P. Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med. 2003;115(5):377–381. doi: 10.1016/s0002-9343(03)00393-0.
    1. Huang CC, Chan WL, Chen YC, Chen TJ, Chou KT, Lin SJ, Chen JW, Leu HB. Statin use in patients with asthma: a nationwide population-based study. Eur J Clin Invest. 2011;41(5):507–512. doi: 10.1111/j.1365-2362.2010.02434.x.
    1. Tardif JC, L'Allier PL, Ibrahim R, Grégoire JC, Nozza A, Cossette M, Kouz S, Lavoie MA, Paquin J, Brotz TM, et al. Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome. Circ Cardiovasc Imaging. 2010;3(3):298–307. doi: 10.1161/CIRCIMAGING.110.937169.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅